| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.004 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |